- Country: USA
- Summary: Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial not Allowed)
- UST Ref No: 64588043
- Deadline: 07 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-126
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
CFDA Number : 93.394 -- Cancer Detection and Diagnosis Research93.859 -- Biomedical Research and Research Training93.866 -- Aging Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: May 07, 2025
Posted Date : Mar 21, 2022
Description: This initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high risk approaches with potential for significant impact. Projects should entail a high degree of risk or novelty, which will be offset by a correspondingly high potential impact. However, the possible impact is likely to be far off. Application of the proposed technology to specific biomedical questions is considered beyond the scope of the program, should not be included, and would not be funded. The goal of this FOA is to support proof of concept studies for feasibility and exploratory technology development. Feasibility must not have already been established in the literature or with preliminary data. Published data can be used to establish the current state of the art but cannot forecast or predict project outcomes. Preliminary data for any purpose might appear to forecast the likelihood of success. Therefore, no unpublished data is allowed. While unpubl... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTechnology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial not Allowed). This tender is published on USARFP under UST Ref No: 64588043 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
